Timothy Wright
InvestorGeneral Partner at Time BioVentures
San Diego, California
Writes $100K – $5M checks · typically $1.5M
About
Dr. Wright is a physician-scientist whose career spans academic research, clinical medicine, big pharma, and biotech, contributing to the development of twenty marketed drugs, ten of which reached over $1 billion in annual sales. He earned his medical degree and completed a rheumatology fellowship and molecular biology and immunology post-docs at Johns Hopkins, later serving on faculty there and as a tenured Associate Professor and Division Chief at the University of Pittsburgh School of Medicine. His industry roles include positions at Pfizer, senior translational and development leadership at Novartis, Executive Vice President at CALIBR, and Chief R&D Officer at Regulus Therapeutics.
Contact· self-published, not guessed
Invests in
Biotech
Experience
- TIME BioVenturesGeneral Partnercurrent2019 — presentLos Angeles - San Diego
- Kling BiotherapeuticsInterim CEOcurrent2025 — presentAmsterdam, NL
- GX Molecular IncInterim CEO2023 — 2024Cambridge, England, United Kingdom
- Regulus TherapeuticsChief Research and Development Officer2016 — 201910614 Science Center Dr, San Diego, CA 92121
- California Institute for Biomedical ResearchExecutive Vice President, Translational Sciences2015 — 201611119 North Torrey Pines Road, La Jolla CA 92037
- NovartisGlobal Head, Pharma Development2011 — 2015Basel, Switzerland
- NovartisSenior Vice President, Global Head of Translational Sciences2007 — 2011Cambridge, MA
- NovartisVice President, Global Head of Translational Medicine2006 — 2007Cambridge, MA
- NovartisVice President, Exploratory Clinical Development2004 — 2006Cambridge, MA
- PfizerSenior Director2001 — 2004Ann Arbor, MI
- University of PittsburghAssistant/Associate Professor (tenured)/Division Chief1991 — 2001Greater Pittsburgh Area
- Johns Hopkins UniversityPostdoctoral Fellow/Instructor/Assistant Professor1983 — 1985Baltimore, Maryland Area
Skills & more
Clinical Trials7Clinical Development8Science2Oncology1Infectious DiseasesLifesciences1Pharmacology7Technology Transfer1Drug Development12Immunology9GLP1GCP2
+8 more
NeuroscienceTherapeutic AreasBiotechnologyDrug DiscoveryLife SciencesPharmaceutical IndustryCROCTMSFrom Timothy's professional profile.
Investments
Board seats
CureVacSchrodinger
Per the firm's website.
Colleagues at Time BioVentures
Bradford Cornell
Advisor at Time BioVentures
D.A. Wallach
General Partner at Time BioVentures
Daniel L. Vasella, M.D.
Advisor at Time BioVentures
Jay Flatley
Advisor at Time BioVentures
Jim Allison, Ph.D.
Scientific Advisor at Time BioVentures
Leonard Schaeffer
Advisor at Time BioVentures
Pam Sharma, M.D., Ph.D.
Scientific Advisor at Time BioVentures
Paul McEwan
Scientific Advisor at Time BioVentures
Network1
Investors connected to Timothy in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Timothy Wright?
- Dr. Wright is a physician-scientist whose career spans academic research, clinical medicine, big pharma, and biotech, contributing to the development of twenty marketed drugs, ten of which reached over $1 billion in annual sales. He earned his medical degree and completed a rheumatology fellowship and molecular biology and immunology post-docs at Johns Hopkins, later serving on faculty there and as a tenured Associate Professor and Division Chief at the University of Pittsburgh School of Medicine. His industry roles include positions at Pfizer, senior translational and development leadership at Novartis, Executive Vice President at CALIBR, and Chief R&D Officer at Regulus Therapeutics.
- Where does Timothy Wright work?
- Timothy Wright is General Partner at Time BioVentures.
- What does Timothy Wright invest in?
- Timothy Wright invests in Biotech.
- What check size does Timothy Wright write?
- Timothy Wright typically writes checks of $100K – $5M.
- What boards does Timothy Wright sit on?
- Timothy Wright holds tracked board seats at CureVac, Schrodinger.
- Where did Timothy Wright go to school?
- Timothy Wright studied at The Johns Hopkins University School of Medicine (Doctor of Medicine (MD)); University of Delaware (Bachelor of Arts (B.A.), Biology/Biological Sciences, General).
Are you in our directory? — or find your own page and tap it there to see your paths to every investor.
Same school
Also attended The Johns Hopkins University School of Medicine59
Hal PazInvestor at Khosla VenturesRochelle WalenskyExecutive Partner at Flare Capital PartnersBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersStephen P. ZacharyManaging Partner at Sands Capital VenturesS.K. LeeExecutive Coach at Roble VenturesEric HsuAnalyst, Private Equity at Sofinnova Ventures
.png)
+ 53 more
Also attended University of Delaware127
Michael MignanoGeneral Partner at Union Square Ventures (USV)Erik RannalaCo-Founder & Partner at Mucker CapitalBrendan FureyChief Compliance Officer at MPM BioImpactMollie RiceAccounting Manager at Golden SeedsIvan LearmontVice President, Information Technology & Facilities at Northpond VenturesJames MassaquoiSenior Investment Associate at Glasswing Ventures
+ 121 more
Shared employers
Also worked at GX Molecular Inc2
Also worked at California Institute for Biomedical Research7
Manny JuarezFacilities & Lab Manager at Avalon BioVenturesJason RolandAdvisor at Avalon BioVenturesTim Wright, M.D.General Partner at Time BioVenturesSwaminathan KDirector - Operations at Pidilite Industries LimitedTravis YoungInvestor at Foresite LabsDennis WhiteExecutive Officer, Director at Cytodyme
+ 1 more
Also worked at Novartis201
Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures
+ 195 more
Also worked at Pfizer229
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesMichael TaylorOperating Partner at Mission Biocapital
+ 223 more